Literature DB >> 10698410

Complementary nature of radiotracer parathyroid imaging and intraoperative parathyroid hormone assays in the surgical management of primary hyperparathyroid disease: case report and review.

R H Wilkinson1, G S Leight, S C Garner, S Borges-Neto.   

Abstract

PURPOSE: This article illustrates the complementary nature of preoperative radionuclide parathyroid imaging and intraoperative rapid parathyroid hormone (PTH) assays in primary hyperparathyroid disease. The authors review the literature on these procedures and compare this protocol and its cost-effectiveness with those of the classic four-gland exploration.
MATERIALS AND METHODS: Preoperative parathyroid imaging with Tc-99m MIBI and intraoperative rapid PTH assays were performed at the time of neck exploration.
RESULTS: One of two parathyroid adenomas seen on radionuclide images would have been missed if the authors had relied solely on the initial decrease in PTH assay value to a normal level.
CONCLUSIONS: Tc-99m MIBI imaging and intraoperative rapid PTH assays are complementary; when used together, they lessen the likelihood that abnormal parathyroid glands will be overlooked. This experience and that of others suggest these combined procedures are cost-effective.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698410     DOI: 10.1097/00003072-200003000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Unexpected results using rapid intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.

Authors:  Ignazio Emmolo; Herbert Dal Corso; Giorgio Borretta; Gianluca Visconti; Alessandro Piovesan; Flora Cesario; Felice Borghi
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

2.  Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement.

Authors:  Richard E Goldstein; Dean Billheimer; William H Martin; Ken Richards
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.